Two Sigma Investments
BNTC icon

Two Sigma Investments’s Benitec Biopharma BNTC Stock Holding History

Two Sigma Investments’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,573
Closed -$5.61K – 3020
2023
Q1 		$5.61K Sell
1,573
-130
-8% -$530 ﹤0.01% 2909
2022
Q4 		$4.92K Sell
1,703
-582
-25% -$1.97K ﹤0.01% 2752
2022
Q3 		$14K Buy
+2,285
New +$29K ﹤0.01% 2396
2021
Q1 		– Sell
-3,361
Closed -$171K – 3828
2020
Q4 		$171K Buy
+3,361
New +$167K ﹤0.01% 3142

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments's BNTC Position: Q2 2023 in Review

Two Sigma Investments sold out of Benitec Biopharma (BNTC) in Q2 2023, closing a stake of 1,573 shares — an estimated $5.61K sold.

Two Sigma Investments first reported a position in BNTC in Q4 2020 and held it in 4 quarters. The position peaked at $171K in Q4 2020. 17 funds tracked by Wall St. Rank hold BNTC as of Q2 2023.

  • Two Sigma Investments reported no remaining Benitec Biopharma position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Investments sold 1,573 Benitec Biopharma shares in Q2 2023, an estimated $5.61K.
  • Two Sigma Investments first reported a position in Benitec Biopharma in Q4 2020 and held it in 4 quarters.
  • Two Sigma Investments's Benitec Biopharma position peaked at $171K in Q4 2020.
  • 17 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.